Dr Marcin Imieliński
Meet Marcin, a co-investigator on SAMBAI
Dr. Imieliński is a physician-scientist whose research is focused on understanding patterns of somatic genetic variation in human cancer, particularly structural variants that rearranges, delete, and/or copy large segments of DNA. His laboratory has developed new approaches to analyze, interpret, and visualize cancer whole genomes, uncovering new classes of genomic rearrangements including those linked to BRCA1 and BRCA2 deficiency.
As a molecular genetic pathologist, he is interested in clinical applications of whole genome sequencing to precision oncology. Dr. Imieliński obtained his M.D. and Ph.D. in genomics and computational biology at the University of Pennsylvania School of Medicine, and a B.S. in Computer Science from Rutgers College. He completed his residency and fellowship in molecular pathology at Massachusetts General Hospital and Harvard Medical School followed by postdoctoral research at the Broad Institute and Dana Farber Cancer Institute.
He is currently Director of Cancer Genetics and Genomics at the Perlmutter Cancer Center in the NYU Grossman School of Medicine, where he is also an Associate Professor of Pathology. He is also an attending pathologist at NYU Langone Health and Core Member at the New York Genome Center.